Agilent Technologies to Expand Therapeutics Manufacturing Facility in USA
Agilent Technologies has selected Fluor Corporation to expand its oligonucleotide therapeutics manufacturing facility in Colorado, USA. The unit will include state-of-the-art engineering enhancements such as advanced automation, water reduction strategies and solvent capturing to optimize cost and construction.
United States Juan Hern Agilent Technologies Fluor Corporation Fluor Advanced Technologies Life Sciences Technologies Life Sciences
Source: process-worldwide.com